Related to cancer treatment, CCL2 significantly reduced apoptosis of mouse and human breast cancer cells induced by gentamicin or 5-FU treatment as determined by cleaved caspase-3 expression (129). This evidence concerns the gene CCL2 and breast carcinoma.